The Power of Vascular Innovation

Imagine a readily available, “off the shelf ” bioengineered human acellular vessel (HAV) that could replace a patient’s own blood vessel or create new vascular access for patients who require dialysis, without requiring cells or tissue from the patient. Humacyte is making that happen.


Groundbreaking technology

Our unique process, paired with innovation and continued improvement and evolution, puts us at the forefront.

Making a meaningful impact on patient care.

Why Human Acellular Vessels (HAV)?

From lower costs to fewer operations, HAVs may offer critical benefits.

Our path to success.

With each year, we’ve moved closer to lifesaving treatments.

Join our team and make a difference.

We'd love to
hear from you.

Scroll to Top